 |
PDBsum entry 5ycs
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
Oxidoreductase
|
PDB id
|
|
|
|
5ycs
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
 |
 |
 |
 |
Enzyme class:
|
 |
E.C.1.3.1.9
- enoyl-[acyl-carrier-protein] reductase (NADH).
|
|
 |
 |
 |
 |
 |
Reaction:
|
 |
a 2,3-saturated acyl-[ACP] + NAD+ = a (2E)-enoyl-[ACP] + NADH + H+
|
 |
 |
 |
 |
 |
2,3-saturated acyl-[ACP]
|
+
|
NAD(+)
Bound ligand (Het Group name = )
corresponds exactly
|
=
|
(2E)-enoyl-[ACP]
|
+
|
NADH
|
+
|
H(+)
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Molecule diagrams generated from .mol files obtained from the
KEGG ftp site
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
|
| |
|
DOI no:
|
Biochem Biophys Res Commun
493:28-33
(2017)
|
|
PubMed id:
|
|
|
|
|
| |
|
Structural insights into the dimer-tetramer transition of FabI from Bacillus anthracis.
|
|
H.T.Kim,
S.Kim,
B.K.Na,
J.Chung,
E.Hwang,
K.Y.Hwang.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
Enoyl-ACP reductase (ENR, also known as FabI) has received considerable interest
as an anti-bacterial target due to its essentiality in fatty acid synthesis. All
the FabI structures reported to date, regardless of the organism, are composed
of homo-tetramers, except for two structures: Bacillus cereus and Staphylococcus
aureus FabI (bcFabI and saFabI, respectively), which have been reported as
dimers. However, the reason for the existence of the dimeric form in these
organisms and the biological meaning of dimeric and tetrameric forms of FabI are
ambiguous. Herein, we report the high-resolution crystal structure of a dimeric
form of Bacillus anthracis FabI (baFabI) and the crystal structures of
tetrameric forms of baFabI in the apo state and in complex with
NAD+and with NAD+-triclosan, at 1.7 Å, 1.85 Å,
1.96 Å, and 1.95 Å, respectively. Interestingly, we found that baFabI with a
His6-tag at its C-terminus exists as a dimer, whereas untagged-baFabI
exists as a tetramer. The His6-tag may block the dimer-tetramer
transition, since baFabI has relatively short-length amino acids
(255LG256) after the 310-helix η7 compared to
those of FabI of other organisms. The dimeric form of baFabI is catalytically
inactive, because the α-helix α5 occupies the NADH-binding site. During the
process of dimer-tetramer transition, this α5 helix rotates about 55° toward
the tetramer interface and the active site is established. Therefore,
tetramerization of baFabI is required for cofactor binding and catalytic
activity.
|
|
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
');
}
}
 |